Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation
Authors:
- 20 April 2007
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 22 (8) , 1040-1049
Abstract
To report the safety and efficacy of intraoperative mitomycin (MMC) augmentation of combined phacoemulsification and deep sclerectomy (PDS). Retrospective, non-randomized, comparative, interventional case series of 119 eyes (63 with and 56 without MMC augmentation) of 119 patients who had PDS between September 2001 and April 2004. The mean follow-up was 23 months (range 12–41 months). There were no differences in the baseline characteristics of the two groups except that patients from the phacoemulsification and deep sclerectomy with mitomycin C (PDS-MMC) group were on average, younger by 3 years (P=0.01). Two years after surgery, the probability of maintaining an IOP below 19 and 15 mmHg without glaucoma medications or needle revision was 76 and 62% in the PDS-MMC group and 62 and 45% in the PDS-no MMC group (P=0.02 and 0.04, respectively). Nd:YAG laser goniopuncture was performed in 71.4% of eyes in the PDS-no MMC and 61.9% of the PD-MMC group (P=0.33). Needle revision was performed in 21.4% of the PDS-no MMC and 17.4% of the PDS-MMC group (P=0.65). Ten patients (8.4%) lost more than two lines of Snellen's visual acuity during follow-up, with no difference between the groups. There were few serious complications related to MMC use (hypotony in one eye after laser goniopuncture). The overall incidence of transconjunctival oozing in the PDS-MMC group was 9.5% compared with 5.4% in the PDS-no MMC group. This study demonstrates that augmentation of PDS with MMC is safe. MMC augmentation appears to increase the probability of achieving lower target intraocular pressures after combined PDS.Keywords
This publication has 32 references indexed in Scilit:
- Intraoperative Mitomycin C for glaucoma surgeryCochrane Database of Systematic Reviews, 2005
- Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomyBritish Journal of Ophthalmology, 2005
- Deep sclerectomy augmented with mitomycin CEye, 2005
- Deep Sclerectomy Versus Punch Trabeculectomy with or without PhacoemulsificationJournal of Glaucoma, 2004
- Gonioscopic view of the trabeculo‐Descemet's membrane after deep sclerectomyActa Ophthalmologica Scandinavica, 2004
- Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin COphthalmology, 2003
- Effect of technique on intraocular pressure after combined cataract and glaucoma surgeryOphthalmology, 2002
- The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deteriorationAmerican Journal of Ophthalmology, 2000
- Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open- angle glaucoma11The authors have no proprietary or financial interest in any product of this study.Ophthalmology, 2000
- The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedureOphthalmology, 1998